Medical Editor: John P. Cunha, DO, FACOEP
Tussigon Tablets (hydrocodone bitartrate and homatropine methylbromide) is a combination of a narcotic cough medicine and a medicine that works against the narcotic to prevent an overdose used to treat cough. Common side effects of Tussigon include:
- mental clouding,
- impairment of mental and physical performance,
- psychic dependence,
- mood changes,
- urinary retention,
- respiratory depression,
- skin rash, and
The adult dose of Tussigon is one (1) tablet every 4 to 6 hours as needed; do not exceed six (6) tablets in 24 hours. The dose of Tussigon for children 6 to 12 years of age is one-half (1/2) tablet every 4 to 6 hours as needed; do not exceed three (3) tablets in 24 hours. Tussigon may interact with narcotics, antihistamines, antipsychotics, antianxiety agents, other CNS depressants (including alcohol), MAO inhibitors, and tricyclic antidepressants. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using Tussigon; it is unknown how it will affect a fetus. Babies born to mothers who have been taking opioids such as hydrocodone in Tussigon regularly prior to delivery will be physically dependent. It is unknown if Tussigon passes into breast milk. Breastfeeding while using Tussigon is not recommended. Withdrawal symptoms may occur if you suddenly stop taking Tussigon.
Our Tussigon Tablets (hydrocodone bitartrate and homatropine methylbromide) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Central Nervous System
Nausea and vomiting may occur; they are more frequent in ambulatory than in recumbent patients.
Prolonged administration of TUSSIGON may produce constipation.
Ureteral spasm, spasm of vesicle sphincters and urinary retention have been reported with opiates.
Skin rash, pruritus.
Read the entire FDA prescribing information for Tussigon (Hydrocodone Bitartrate and Homatropine Methylbromide Tablets)
© Tussigon Patient Information is supplied by Cerner Multum, Inc. and Tussigon Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.